Sandip Kapadia's most recent trade in Skyward Specialty Insurance Group Inc was a trade of 4,326 2026 Bright Future - RSUs done . Disclosure was reported to the exchange on Feb. 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 4,326 | 4,326 | - | - | 2026 Bright Future - RSUs | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 2,884 | 2,884 | - | - | 2026 LTIP - PSUs | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2026 | 2,884 | 2,884 | - | - | 2026 LTIP - RSUs | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2026 | 2,343 | 17,888 | - | 0 | Common Stock | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2026 | 2,020 | 0 | - | - | 2023 LTIP - PSUs | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.89 per share. | 25 Feb 2026 | 847 | 17,041 | - | 45.9 | 38,869 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.15 per share. | 26 Jan 2026 | 3,746 | 24,521 | - | 37.2 | 139,171 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 42,600 | 42,600 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 12,200 | 12,200 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 4,725 | 14,175 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 4,725 | 4,725 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 3,813 | 7,625 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 3,813 | 3,813 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.82 per share. | 22 Jan 2026 | 2,553 | 2,172 | - | 36.8 | 94,001 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.82 per share. | 22 Jan 2026 | 2,239 | 1,574 | - | 36.8 | 82,440 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 35.92 per share. | 15 Jan 2026 | 20,961 | 0 | - | 35.9 | 752,833 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 5,000 | 14,338 | - | 0 | Common Stock | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 5,000 | 17,353 | - | 0 | Common Stock | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 5,000 | 0 | - | - | 2023 IPO RSU Grant (3-Year) | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2026 | 5,000 | 5,000 | - | - | 2023 IPO RSU Grant (4-Year) | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.10 per share. | 12 Jan 2026 | 1,985 | 12,353 | - | 46.1 | 91,509 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.10 per share. | 12 Jan 2026 | 1,808 | 15,545 | - | 46.1 | 83,349 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 2,020 | 0 | - | - | 2023 LTIP - RSUs | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 2,020 | 10,079 | - | 0 | Common Stock | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.11 per share. | 01 Jan 2026 | 741 | 9,338 | - | 51.1 | 37,873 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 18 Dec 2025 | 5,030 | 8,059 | - | 50.0 | 251,550 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Sale of securities on an exchange or to another person at price $ 50.03 per share. | 12 Dec 2025 | 1,486 | 14,289 | - | 50.0 | 74,345 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | Head of Actuarial | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 12 Dec 2025 | 1,200 | 13,089 | - | 50.0 | 60,012 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.54 per share. | 05 Dec 2025 | 20,000 | 0 | - | 39.5 | 790,896 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2025 | 20,000 | 185,000 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.03 per share. | 05 Dec 2025 | 20,000 | 20,000 | - | 29.0 | 580,600 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 21 Nov 2025 | 3,427 | 0 | - | 35 | 119,945 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 45,000 | 45,000 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 45,000 | 45,000 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.56 per share. | 30 Sep 2025 | 24,039 | 20,961 | - | 27.6 | 662,515 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 36.50 per share. | 15 Aug 2025 | 21,573 | 0 | - | 36.5 | 787,378 | Common Stock |
| Passage Bio Inc | Sandip S. Kapadia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 201,857 | 201,857 | - | - | Director Stock Option (right to buy) | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.48 per share. | 01 Apr 2025 | 6,247 | 740 | - | 32.5 | 202,881 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.11 per share. | 01 Apr 2025 | 740 | 0 | - | 33.1 | 24,505 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2025 | 15,000 | 15,000 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2025 | 15,000 | 15,000 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.19 per share. | 29 Mar 2025 | 8,014 | 6,986 | - | 33.2 | 265,985 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 5,000 | 5,000 | - | - | 2023 IPO RSU Grant (3-Year) | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 5,000 | 17,213 | - | - | Common Stock | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 2,937 | 13,308 | - | - | Common Stock | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 2,937 | 0 | - | - | 2022 LTIP - PSUs | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 50.24 per share. | 06 Mar 2025 | 1,866 | 15,347 | - | 50.2 | 93,748 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 50.24 per share. | 06 Mar 2025 | 1,095 | 12,213 | - | 50.2 | 55,013 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 1,520 | 1,520 | - | - | 2025 LTIP - PSUs | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 1,520 | 1,520 | - | - | 2025 LTIP - RSUs | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 1,520 | 1,520 | - | - | 2025 LTIP - PSUs | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 66,250 | 66,250 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 18,900 | 18,900 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 3,812 | 3,812 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 3,812 | 11,438 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.01 per share. | 24 Jan 2025 | 2,037 | 1,775 | - | 38.0 | 77,426 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.05 per share. | 24 Jan 2025 | 1,775 | 0 | - | 38.1 | 67,547 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.18 per share. | 21 Jan 2025 | 25,000 | 0 | - | 40.2 | 1,004,598 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2025 | 25,000 | 205,000 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.03 per share. | 21 Jan 2025 | 25,000 | 25,000 | - | 29.0 | 725,750 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 49.51 per share. | 02 Jan 2025 | 4,347 | 12,508 | - | 49.5 | 215,233 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 47.65 per share. | 02 Jan 2025 | 678 | 11,279 | - | 47.7 | 32,309 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 47.82 per share. | 02 Jan 2025 | 551 | 11,957 | - | 47.8 | 26,350 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 46.97 per share. | 02 Jan 2025 | 464 | 10,371 | - | 47.0 | 21,792 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 46.99 per share. | 02 Jan 2025 | 444 | 10,835 | - | 47.0 | 20,864 | Common Stock |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 60,000 | 90,000 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 60,000 | 60,000 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.00 per share. | 30 Sep 2024 | 32,052 | 27,948 | - | 40 | 1,282,080 | Common Stock |
| Passage Bio Inc | Sandip S. Kapadia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 47,693 | 47,693 | - | - | Director Stock Option (right to buy) | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2024 | 15,000 | 15,000 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2024 | 15,000 | 15,000 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 29 Mar 2024 | 8,013 | 6,987 | - | 33.6 | 269,077 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 1,745 | 1,745 | - | - | 2024 LTIP - Performance Share Units | |
| Skyward Specialty Insurance Grp Inc | Kapadia Sandip | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 1,745 | 1,745 | - | - | 2024 LTIP - Common Stock | |
| Harmony Biosciences Holdings Inc | S. Sandip Kapadia | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 74,250 | 74,250 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Kapadia Sandip S. | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 15,250 | 15,250 | - | - | Restricted Stock Units | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 3,968 | 0 | - | - | Restricted Stock Unit | |
| Skyward Specialty Insurance Grp Inc | Kapadia Sandip | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 3,968 | 16,140 | - | - | Common Stock | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 1,394 | 0 | - | - | Restricted Stock Unit | |
| Skyward Specialty Insurance Grp Inc | Kapadia Sandip | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 1,394 | 12,172 | - | - | Common Stock | |
| Passage Bio Inc | Sandip S. Kapadia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 24,000 | 24,000 | - | - | Director Stock Option (Right to Buy) | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 30,000 | 30,000 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.36 per share. | 29 Mar 2023 | 15,414 | 14,586 | - | 33.4 | 514,211 | Common Stock |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 2,020 | 2,020 | - | - | 2023 LTIP - Performance Share Units | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 2,020 | 2,020 | - | - | 2023 LTIP - Common Stock | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 40,000 | 40,000 | - | - | 2023 Stock Options (Right to Buy) | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 10,000 | 10,000 | - | - | 2023 RSU Grant (4-Year) | |
| Skyward Specialty Insurance Grp Inc | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 10,000 | 10,000 | - | - | 2023 RSU Grant (3-Year) | |
| Passage Bio Inc | Sandip S. Kapadia | Director | Sale of securities on an exchange or to another person at price $ 1.19 per share. | 01 Dec 2022 | 5,000 | 0 (0%) | 0% | 1.2 | 5,965 | Common Stock |
| Passage Bio Inc | Sandip S. Kapadia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 24,000 | 24,000 | - | - | Director Stock Option (Right to Buy) | |
| Passage Bio Inc | Sandip S. Kapadia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 16,918 | 16,918 | - | - | Director Stock Option (Right to Buy) |